NCT02882295

Brief Summary

Writer's cramp (WC) is a task specific dystonia that occurs from the moment patient starts writing. It leads to partial or complete inability to use the hand only during the handwriting gesture. It is characterized by the appearance of cramps or spasms of certain muscles of the hand and/or forearm. Clinical scales currently use for the assessment of WC fail to accurately reflect changes in the characteristics of handwriting in response to treatments (Botulinum Neurotoxin injections and / or retraining therapy). The Zigzag Tracking Task (ZZTT), easy to use in current practice provides useful information in terms of speed and precision of handwriting gesture. This timed handwriting test is to follow with a pen a zigzag path beset with obstacles to avoid. It permits to evaluate the time in seconds required to carry out the zigzag path and count the number of errors (output path and contacts with obstacles). The investigators propose to validate the ZZTT for the assessment of the handwriting gesture of WC.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 29, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2017

Completed
Last Updated

April 14, 2022

Status Verified

April 1, 2022

Enrollment Period

1.4 years

First QC Date

August 24, 2016

Last Update Submit

April 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • hand-writing speed

    speed and accuracy of handwriting

    immediate

Study Arms (2)

writer's cramp

patients assessed without, then with Botulinum Neurotoxin injections

Other: Validation of a handwriting scale

control

age and gender matched

Other: Validation of a handwriting scale

Interventions

controlwriter's cramp

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients suffering from writer's cramp and healthy subjects, age and gender matched

You may qualify if:

  • scholarship in French language, at least until 16 years old
  • writer's cramp (diagnostic confirmed by a neurologist specialized in movement disorders)
  • prescription of botulinum neurotoxin injection
  • prescription de novo or absence of injection in the last 3 months
  • informed consent
  • medical insurance coverage

You may not qualify if:

  • writing tremor
  • other neurological disease with effect on handwriting
  • pain or traumatism of the upper limb, with effect on handwriting
  • non-corrected visual disturbances
  • patient living outside the region where the study will be held (Ile-de-France)
  • participation in another research with a potential impact on evaluation criteria
  • pregnant or breast feeding patient
  • patient under judiciary protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmique Adolphe de Rothschild

Paris, 75019, France

Location

MeSH Terms

Conditions

Dystonic Disorders

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Jean-Pierre BLETON, PhD

    Fondation OPH A de Rothschild

    STUDY DIRECTOR
  • Sophie SANGLA, MD

    Fondation OPH A de Rothschild

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2016

First Posted

August 29, 2016

Study Start

July 5, 2016

Primary Completion

November 15, 2017

Study Completion

November 15, 2017

Last Updated

April 14, 2022

Record last verified: 2022-04

Locations